EMN Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
Eastman Chemical Co (EMN) is not a strong buy at this moment for a long-term beginner investor. The company's financial performance shows significant declines in key metrics, and while hedge funds are buying, there are no strong positive catalysts or immediate recovery signals. The technical indicators are neutral to slightly bullish, but the lack of significant news, weak financials, and mixed analyst sentiment suggest holding off on this investment for now.
The MACD is positive but contracting, indicating a potential loss of momentum. RSI is neutral at 69.808, and the moving averages are bullish (SMA_5 > SMA_20 > SMA_200). The stock is trading above key support levels (S1: 70.08), but the regular market change of -1.91% and post-market drop of -0.39% suggest weakness. Pivot level is 76.058, with resistance at R1: 82.036 and R2: 85.73.
Hedge funds have significantly increased their buying activity (626.44% increase). Analysts have raised price targets recently, with some maintaining Buy ratings. The stock has a 70% chance of gaining 2.94% in the next month based on candlestick analysis.
The company's Q4 financials showed significant declines in revenue (-12.12% YoY), net income (-68.18% YoY), and EPS (-67.84% YoY). Gross margin also dropped by -30.59%. Analysts highlight ongoing cyclical softness and structural challenges in the chemicals industry. No recent news or congress trading data to support a positive outlook.
In Q4 2025, Eastman Chemical's revenue dropped to $1.973 billion (-12.12% YoY). Net income fell sharply to $105 million (-68.18% YoY), and EPS dropped to $0.91 (-67.84% YoY). Gross margin declined to 17.13% (-30.59% YoY), indicating significant financial struggles.
Analyst sentiment is mixed. RBC Capital raised its price target to $79 but maintains a Sector Perform rating. Citi and BofA have Buy ratings with price targets of $78 and $79, respectively. JPMorgan and Fermium Research have Neutral and Hold ratings, citing weak demand and cyclical softness. Wells Fargo downgraded the stock to Equal Weight, citing trough-like conditions in the industry.
